Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

NCT04422457 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT04422457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04422457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Not applicable
Overall status
Completed
Start date
June 13, 2020
Completion date
March 1, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor